Haw Par Corporation Limited (HAWPF) Stock Price & Analysis
Haw Par Corporation Limited (HAWPF) — price $9.85 (0.00%), as of the Nov 19, 2026 trading session; market cap $2.18B.
Educational signal · not a buy or sell recommendation · How to read this
Haw Par Corporation Limited · HAWPF
Haw Par Corporation Limited is a diversified Singaporean conglomerate with core operations in healthcare, primarily through its globally recognized Tiger Balm and Kwan Loong brands. The company also maintains significant interests in investment properties and a portfolio of quoted securities, alongside a leisure segment featuring oceanariums. This multi-faceted structure provides varied revenue streams across different sectors and geographies.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Scored companies in the same industry:
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $9.85 | |
| Change on the day | 0.00% | |
| 52-week range | $9.85 – $14.17 | |
| Market capitalisation | $2.18B | — |
| Price / earnings (trailing) | 11.76 | |
| Shares traded on the day | 200 |
Price & events
Other perspectives
Council score for Haw Par Corporation (HAWPF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
4 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 8, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Apr 30, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Apr 30, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Haw Par Corporation (HAWPF), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Haw Par Corporation Limited (HAWPF) is the company analyzed here. It employs 595 people and is led by Ee Lim Wee. In Q2 FY2026 it reported revenue of S$116M and net income of S$108M. The market values it at $2.18B.
What do the latest results show for Haw Par Corporation (HAWPF)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of S$116M.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | S$116M | S$108M | S$0.49 (diluted) |
| Q4 FY2025 | S$104M | S$121M | S$0.55 (diluted) |
| Q2 FY2025 | S$126M | S$144M | S$0.65 (diluted) |
| Q4 FY2024 | S$127M | S$106M | S$0.48 (diluted) |
What are the financial strengths and risks for Haw Par Corporation (HAWPF)?
Short answer · as of
The distress and quality screens read Altman Z 13.36 · Piotroski F 4. Trailing ratios: ROE 5.1% · ROA 4.7% · current ratio 7.17 · earnings yield 8.3% · free-cash-flow yield 8.2%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held HAWPF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported HAWPF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Investor Questions: HAWPF Stock
These answers are editorial: 1 of these 8 answers is drawn from the HAWPF research dossier (written Jun 15, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is HAWPF a good stock to buy?
Stock Expert AI does not rate HAWPF buy, sell or hold. Haw Par Corporation Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the HAWPF stock price today?
The last price recorded for Haw Par Corporation Limited (HAWPF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the main risks for HAWPF?
Haw Par Corporation Limited faces several key risks inherent to its diversified operations. In the healthcare segment, intense competition from both established pharmaceutical companies and emerging brands poses a continuous threat to market share and pricing power for its Tiger Balm and Kwan Loong products.
What are the key factors to evaluate for HAWPF?
Evaluate HAWPF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Strategic Growth of the Investment Portfolio: The company's Investments segment, which primarily invests in quoted securities, offers a dynamic avenue for growth. Not financial advice.
How frequently does HAWPF data refresh on this page?
HAWPF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven HAWPF's recent stock price performance?
Haw Par Corporation Limited (HAWPF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Globally recognized and trusted healthcare brands (Tiger Balm, Kwan Loong) with strong market presence. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HAWPF overvalued or undervalued right now?
The trailing P/E of Haw Par Corporation Limited (HAWPF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research HAWPF before investing?
Before investing in Haw Par Corporation Limited (HAWPF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 14 figures on this page — 8 from Financial Modeling Prep (FMP) and 6 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com